Individual research recommendation details

Recommendation ID

MTG76/1

Question

Long-term real-world data is needed on AposHealth's clinical effectiveness and cost benefit

Any explanatory notes
(if applicable)

The committee suggested that real-world data could be collected to determine the clinical effectiveness and cost benefit of AposHealth for people whose condition meets the criteria for surgery but who do not want it over a longer time horizon. The committee noted that there is already a high quality RCT comparing AposHealth with a sham device and acknowledged that there are difficulties in designing comparative studies because of the uncertainties in the standard care pathway. The committee supported the use of the technology in the NHS alongside the collection of high quality real-world data, with outcomes including standard care resource use, health-related quality of life, and long-term outcomes such as rates of total knee replacement. The committee suggested that this data could be collected through a high-qualitynational registry (such as the National Joint Registry). The committee agreed that long-term data collection over 5 to 10 years will help establish the cost benefits of AposHealth.

Source guidance details

Comes from guidance

AposHealth for knee osteoarthritis

Number

MTG76

Date issued

April 2023

Other details